Brief: Gentian Signs Global Distribution Agreement With Diagnostic Company
Oct 27 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* SIGNS DISTRIBUTION AGREEMENT WITH A MAJOR DIAGNOSTIC
COMPANY FOR
GCAL® CALPROTECTIN IMMUNOASSAY
* HAS ENTERED INTO A GLOBAL DISTRIBUTION AGREEMENT FOR ITS
GCAL®
CALPROTECTIN IMMUNOASSAY WITH A MAJOR DIAGNOSTIC COMPANY
Source text for Eikon: ID:nObimCLRja
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Gentian Diagnostics Q3 Sales At NOK 51.1 Million
Brief: Gentian Diagnostics Q2 EBITDA At NOK 8.1 Mln
Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
Brief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership